Literature DB >> 24449256

Management of recurrent thrombosis in antiphospholipid syndrome.

Cecilia Nalli1, Laura Andreoli, Cinzia Casu, Angela Tincani.   

Abstract

One of the challenges of managing patients with antiphospholipid syndrome is the prevention of rethrombosis (secondary prophylaxis). Risk stratification, i.e. traditional cardiovascular and thrombosis risk factors, systemic autoimmune diseases, antiphospholipid antibody profile, and the intensity of anticoagulation are all relevant to the management of APS patients with recurrent thrombosis. The paper will review "state of the art" strategies for optimizing therapy for APS patients with recurrent thrombosis.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24449256     DOI： 10.1007/s11926-013-0405-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  48 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 2.  Secondary prevention in thrombotic antiphospholipid syndrome.

Authors:  V Pengo; G Denas; A Banzato; E Bison; A Bracco; M Facchinetti; A Hoxha; A Ruffatti
Journal:  Lupus       Date:  2012-06       Impact factor: 2.911

Review 3.  Correct laboratory approach to APS diagnosis and monitoring.

Authors:  V Pengo; A Banzato; G Denas; S Padayattil Jose; E Bison; A Hoxha; A Ruffatti
Journal:  Autoimmun Rev       Date:  2012-12-03       Impact factor: 9.754

Review 4.  Management of antiphospholipid antibody syndrome: a systematic review.

Authors:  Wendy Lim; Mark A Crowther; John W Eikelboom
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

5.  A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Authors:  G Finazzi; R Marchioli; V Brancaccio; P Schinco; F Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; T Barbui
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

6.  Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Authors:  M H Rosove; P M Brewer
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

Review 7.  Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

Authors:  Pier Luigi Meroni; M Orietta Borghi; Elena Raschi; Francesco Tedesco
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

Review 8.  Hypercoagulability syndromes.

Authors:  R H Thomas
Journal:  Arch Intern Med       Date:  2001-11-12

9.  Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.

Authors:  Laura Andreoli; Cecilia B Chighizola; Alessandra Banzato; Guillermo J Pons-Estel; Guilherme Ramire de Jesus; Doruk Erkan
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-11       Impact factor: 4.794

10.  The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.

Authors:  Gabriela Hernández-Molina; Grissel Espericueta-Arriola; Antonio R Cabral
Journal:  Clin Exp Rheumatol       Date:  2013-01-10       Impact factor: 4.473
View more
  9 in total

Review 1.  Difficult clinical situations in the antiphospholipid syndrome.

Authors:  Renata Ferreira Rosa; Michelle Remião Ugolini-Lopes; Audrey Krüse Zeinad-Valim; Elbio D'Amico; Danieli Andrade
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 2.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

3.  Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke.

Authors:  Wookjin Yang; Dong-Wan Kang; Jeong-Min Kim; Keun-Hwa Jung; Seung-Hoon Lee
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

Review 4.  The antiphospholipid syndrome: from pathophysiology to treatment.

Authors:  Simone Negrini; Fabrizio Pappalardo; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2016-06-22       Impact factor: 3.984

5.  The Wolf Hidden behind the Clots: Catastrophic Antiphospholipid Antibody Syndrome.

Authors:  Myat Han Soe; Krishna Adit Agarwal; Alueshima Akough-Weir
Journal:  Case Rep Med       Date:  2018-07-19

Review 6.  Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.

Authors:  Malgorzata M Bala; Magdalena Celinska-Lowenhoff; Wojciech Szot; Agnieszka Padjas; Mateusz Kaczmarczyk; Mateusz J Swierz; Anetta Undas
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

7.  Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.

Authors:  Malgorzata M Bala; Magdalena Celinska-Lowenhoff; Wojciech Szot; Agnieszka Padjas; Mateusz Kaczmarczyk; Mateusz J Swierz; Anetta Undas
Journal:  Cochrane Database Syst Rev       Date:  2020-10-12

Review 8.  Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature.

Authors:  Jariya Waisayarat; Sirithep Plumworasawat; Soamarat Vilaiyuk; Nongnuch Sirachainan
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

9.  Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.

Authors:  Ilan Volkov; Luciana Seguro; Elaine P Leon; László Kovács; Dirk Roggenbuck; Peter Schierack; Boris Gilburd; Andrea Doria; Maria G Tektonidou; Nancy Agmon-Levin
Journal:  Auto Immun Highlights       Date:  2020-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.